L-dopa reverses behavioral deficits in the Pitx3 mouse fetus
Studies of fetal rodents have provided evidence that early emerging behaviors, such as the suckling response, are dependent on the developing dopaminergic system. Although connections have been made between manipulations of dopamine and altered behavioral responses, the specific neural pathways invo...
Saved in:
Published in | Behavioral neuroscience Vol. 128; no. 6; p. 749 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
United States
01.12.2014
|
Subjects | |
Online Access | Get more information |
Cover
Loading…
Abstract | Studies of fetal rodents have provided evidence that early emerging behaviors, such as the suckling response, are dependent on the developing dopaminergic system. Although connections have been made between manipulations of dopamine and altered behavioral responses, the specific neural pathways involved have yet to be discovered. In this study, we examined the neurobehavioral output of the nigrostriatal pathway, using the Pitx3ak/2J mouse model (Pitx3). Used extensively in the study of Parkinson's disease, the Pitx3 mouse has very specific prenatal loss of dopaminergic neurons solely in the nigrostriatal pathway. Because of this specificity, we hypothesized that behavioral deficits specific to the nigrostriatal pathway would be reversed with administration of the dopamine precursor 3,4-dihydroxyphenylalanine (L-dopa). To test this hypothesis, homozygous mutant and heterozygous control fetal subjects were administered 1 of 4 doses (0, 25, 50, or 75 mg/kg) of L-dopa on the day before birth. Quantification of fetal behavior was scored from video recordings of behavioral observations. The behavioral measures used were (a) spontaneous movement activity; (b) state organization, from quantifications of high- and low-amplitude movements; (c) interlimb movement synchrony, a measure of limb coordination; and (d) oral grasp, similar to a newborn infant suckling response. Specific behavioral deficits observed in the Pitx3 mutants were reversed by L-dopa administration in a dose-dependent manner. However, different deficits required dissimilar doses for reversal, suggesting that some early emerging behaviors may be more sensitive to the administration of L-dopa. Taken together, this study provides valuable information about prenatal behaviors dependent on the nigrostriatal pathway. |
---|---|
AbstractList | Studies of fetal rodents have provided evidence that early emerging behaviors, such as the suckling response, are dependent on the developing dopaminergic system. Although connections have been made between manipulations of dopamine and altered behavioral responses, the specific neural pathways involved have yet to be discovered. In this study, we examined the neurobehavioral output of the nigrostriatal pathway, using the Pitx3ak/2J mouse model (Pitx3). Used extensively in the study of Parkinson's disease, the Pitx3 mouse has very specific prenatal loss of dopaminergic neurons solely in the nigrostriatal pathway. Because of this specificity, we hypothesized that behavioral deficits specific to the nigrostriatal pathway would be reversed with administration of the dopamine precursor 3,4-dihydroxyphenylalanine (L-dopa). To test this hypothesis, homozygous mutant and heterozygous control fetal subjects were administered 1 of 4 doses (0, 25, 50, or 75 mg/kg) of L-dopa on the day before birth. Quantification of fetal behavior was scored from video recordings of behavioral observations. The behavioral measures used were (a) spontaneous movement activity; (b) state organization, from quantifications of high- and low-amplitude movements; (c) interlimb movement synchrony, a measure of limb coordination; and (d) oral grasp, similar to a newborn infant suckling response. Specific behavioral deficits observed in the Pitx3 mutants were reversed by L-dopa administration in a dose-dependent manner. However, different deficits required dissimilar doses for reversal, suggesting that some early emerging behaviors may be more sensitive to the administration of L-dopa. Taken together, this study provides valuable information about prenatal behaviors dependent on the nigrostriatal pathway. |
Author | Ronca, April E Kleven, Gale A Booth, Heather M Voogd, Marco |
Author_xml | – sequence: 1 givenname: Gale A surname: Kleven fullname: Kleven, Gale A organization: Department of Psychology – sequence: 2 givenname: Heather M surname: Booth fullname: Booth, Heather M organization: Department of Psychology – sequence: 3 givenname: Marco surname: Voogd fullname: Voogd, Marco organization: Department of Psychology – sequence: 4 givenname: April E surname: Ronca fullname: Ronca, April E organization: Department of Obstetrics and Gynecology |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/25150543$$D View this record in MEDLINE/PubMed |
BookMark | eNo1j8tKBDEQRYMozkM3foDkB1orqaQzDW5k8AUNutD1kHSqmMj0g07PoH-vot7NgbM4cBfiuOs7EuJCwZUCdNehI_iZKo_EXFVYFQArMxOLnN-_tQFjT8VMW2XBGpyLm7qI_eDlSAcaM2UZaOsPqR_9Tkbi1KQpy9TJaUvyJU0fKNt-n0kyTft8Jk7Y7zKd_3Ep3u7vXtePRf388LS-rQtvwUxFw9Yh6cAMATCWEFfgmNA6V5pADtEHqBrLiFEHw1RxCMFZoyLr0rFeisvf7rAPLcXNMKbWj5-b_xv6C8YuSNk |
CitedBy_id | crossref_primary_10_5352_JLS_2015_25_9_1043 crossref_primary_10_1016_j_bbr_2015_01_047 crossref_primary_10_31083_j_jin2301002 |
ContentType | Journal Article |
DBID | CGR CUY CVF ECM EIF NPM |
DOI | 10.1037/bne0000016 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | no_fulltext_linktorsrc |
Discipline | Anatomy & Physiology Psychology |
EISSN | 1939-0084 |
ExternalDocumentID | 25150543 |
Genre | Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: NICHD NIH HHS grantid: HD050201 – fundername: NINR NIH HHS grantid: NR010798 – fundername: NICHD NIH HHS grantid: R01 HD050201 – fundername: NINR NIH HHS grantid: R00 NR010798 – fundername: NINR NIH HHS grantid: K99 NR010798 |
GroupedDBID | --- --Z -DZ -ET -~X .-4 .GJ 0R~ 186 23N 354 53G 5GY 5RE 5VS 7RZ 9M8 AAAHA ABCQX ABIVO ABNCP ABPPZ ABVOZ ACGFO ACIWK ACNCT ACPQG ACPRK ADXHL AEHFB AENEX AFFNX ALEEW ALMA_UNASSIGNED_HOLDINGS AWKKM AZXWR BKOMP CGNQK CGR CS3 CUY CVF DU5 ECM EIF EPA F5P FTD HVGLF HZ~ H~9 ISO L7B LW5 MVM NHB NPM O9- OPA OVD P2P PHGZM PHGZT PQQKQ ROL RXW SES SPA TAE TEORI TN5 TWZ UHB UHS UPT VQP WH7 X6Y XJT XOL YYP YZZ ZCA ZGI ZHY ZPI ZXP ~KM |
ID | FETCH-LOGICAL-a504t-cf573e2bff0b03d60d807fe357764be733ab09c5f33d2b4fe9fbbb7541df267f2 |
IngestDate | Mon Jul 21 06:00:40 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 6 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-a504t-cf573e2bff0b03d60d807fe357764be733ab09c5f33d2b4fe9fbbb7541df267f2 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/4344825 |
PMID | 25150543 |
ParticipantIDs | pubmed_primary_25150543 |
PublicationCentury | 2000 |
PublicationDate | 2014-12-01 |
PublicationDateYYYYMMDD | 2014-12-01 |
PublicationDate_xml | – month: 12 year: 2014 text: 2014-12-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Behavioral neuroscience |
PublicationTitleAlternate | Behav Neurosci |
PublicationYear | 2014 |
References | 12829322 - Brain Res Mol Brain Res. 2003 Jun 10;114(2):123-31 18215235 - Eur J Neurosci. 2008 Jan;27(2):388-95 18980217 - Dev Psychobiol. 2009 Jan;51(1):84-94 1487080 - Dev Psychobiol. 1992 Dec;25(8):543-55 20437561 - Ann Neurol. 2010 May;67(5):639-47 15856447 - Ment Retard Dev Disabil Res Rev. 2005;11(1):4-13 12088309 - Dev Med Child Neurol. 2002 Jun;44(6):405-14 15998204 - Behav Neurosci. 2005 Jun;119(3):821-33 18573342 - Neurobiol Dis. 2008 Sep;31(3):406-12 8381974 - Physiol Behav. 1993 Jan;53(1):191-7 7878109 - Physiol Behav. 1995 Jan;57(1):15-9 17919745 - Behav Brain Res. 2008 Jan 25;186(2):208-14 19825428 - Gene Expr Patterns. 2009 Dec;9(8):555-61 17905480 - Neurobiol Aging. 2009 May;30(5):731-8 12115286 - Dev Psychobiol. 2002 Jul;41(1):1-14 15950611 - Dev Biol. 2005 Jun 15;282(2):467-79 22309633 - Eur J Neurol. 2012 Jun;19(6):870-5 8097042 - Pharmacol Biochem Behav. 1993 Apr;44(4):843-50 7617674 - Pharmacol Biochem Behav. 1995 Mar;50(3):359-67 22429667 - J Neurol Sci. 2012 Jun 15;317(1-2):80-6 15728853 - J Neurosci. 2005 Feb 23;25(8):2132-7 9222113 - Dev Psychobiol. 1997 Jul;31(1):3-17 15649693 - Neurobiol Dis. 2005 Feb;18(1):19-31 17017509 - J Neural Transm Suppl. 2006;(70):57-60 7842501 - Brain Res Dev Brain Res. 1994 Oct 14;82(1-2):136-42 12702666 - Development. 2003 Jun;130(11):2535-42 6121688 - Ciba Found Symp. 1981;86:251-70 8919092 - Dev Psychobiol. 1996 Mar;29(2):139-56 8382637 - Dev Psychobiol. 1993 Jan;26(1):37-50 1933245 - Brain. 1991 Oct;114 ( Pt 5):2283-301 20026251 - Neuroscience. 2010 Mar 17;166(2):391-6 12655058 - Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):4245-50 16269007 - J Neurochem. 2006 Jan;96(1):160-70 15301609 - Behav Neurosci. 2004 Aug;118(4):835-44 6140548 - Lancet. 1983 Dec 24-31;2(8365-66):1457-9 2899295 - Nature. 1988 Jul 28;334(6180):345-8 1387836 - Brain Res Dev Brain Res. 1992 Jul 24;68(1):17-22 18420308 - Neurobiol Aging. 2010 Jan;31(1):114-7 8387314 - Behav Neurosci. 1993 Apr;107(2):370-6 15315815 - Neurotoxicol Teratol. 2004 Sep-Oct;26(5):663-71 22820144 - Neurobiol Dis. 2012 Dec;48(3):271-81 16565358 - Invest Ophthalmol Vis Sci. 2006 Apr;47(4):1274-80 8719180 - Dev Psychobiol. 1996 Jan;29(1):1-22 2029768 - Brain Res Dev Brain Res. 1991 Feb 22;58(2):251-5 1394974 - Brain Res Dev Brain Res. 1992 Aug 21;68(2):286-8 11247667 - Genomics. 2001 Feb 15;72(1):61-72 14973278 - Development. 2004 Mar;131(5):1145-55 23489835 - Eur J Neurosci. 2013 May;37(10):1564-72 12369810 - Behav Neurosci. 2002 Oct;116(5):912-7 5276777 - Proc Natl Acad Sci U S A. 1971 Mar;68(3):662-6 10861284 - Hum Mol Genet. 2000 Jul 1;9(11):1575-85 22411443 - Swiss Med Wkly. 2012;142:w13521 2873069 - Eur J Obstet Gynecol Reprod Biol. 1986 May;21(5-6):341-6 7938130 - Pharmacol Biochem Behav. 1994 Jul;48(3):741-8 16243425 - Prog Neurobiol. 2005 Sep-Oct;77(1-2):128-38 12373520 - Amino Acids. 2002;23(1-3):65-70 |
References_xml | – reference: 15315815 - Neurotoxicol Teratol. 2004 Sep-Oct;26(5):663-71 – reference: 17017509 - J Neural Transm Suppl. 2006;(70):57-60 – reference: 8719180 - Dev Psychobiol. 1996 Jan;29(1):1-22 – reference: 22411443 - Swiss Med Wkly. 2012;142:w13521 – reference: 2899295 - Nature. 1988 Jul 28;334(6180):345-8 – reference: 11247667 - Genomics. 2001 Feb 15;72(1):61-72 – reference: 18420308 - Neurobiol Aging. 2010 Jan;31(1):114-7 – reference: 15649693 - Neurobiol Dis. 2005 Feb;18(1):19-31 – reference: 12369810 - Behav Neurosci. 2002 Oct;116(5):912-7 – reference: 8097042 - Pharmacol Biochem Behav. 1993 Apr;44(4):843-50 – reference: 15728853 - J Neurosci. 2005 Feb 23;25(8):2132-7 – reference: 8381974 - Physiol Behav. 1993 Jan;53(1):191-7 – reference: 6140548 - Lancet. 1983 Dec 24-31;2(8365-66):1457-9 – reference: 23489835 - Eur J Neurosci. 2013 May;37(10):1564-72 – reference: 7617674 - Pharmacol Biochem Behav. 1995 Mar;50(3):359-67 – reference: 10861284 - Hum Mol Genet. 2000 Jul 1;9(11):1575-85 – reference: 2873069 - Eur J Obstet Gynecol Reprod Biol. 1986 May;21(5-6):341-6 – reference: 1394974 - Brain Res Dev Brain Res. 1992 Aug 21;68(2):286-8 – reference: 8919092 - Dev Psychobiol. 1996 Mar;29(2):139-56 – reference: 2029768 - Brain Res Dev Brain Res. 1991 Feb 22;58(2):251-5 – reference: 7938130 - Pharmacol Biochem Behav. 1994 Jul;48(3):741-8 – reference: 9222113 - Dev Psychobiol. 1997 Jul;31(1):3-17 – reference: 19825428 - Gene Expr Patterns. 2009 Dec;9(8):555-61 – reference: 20026251 - Neuroscience. 2010 Mar 17;166(2):391-6 – reference: 12088309 - Dev Med Child Neurol. 2002 Jun;44(6):405-14 – reference: 12115286 - Dev Psychobiol. 2002 Jul;41(1):1-14 – reference: 6121688 - Ciba Found Symp. 1981;86:251-70 – reference: 8382637 - Dev Psychobiol. 1993 Jan;26(1):37-50 – reference: 7878109 - Physiol Behav. 1995 Jan;57(1):15-9 – reference: 16565358 - Invest Ophthalmol Vis Sci. 2006 Apr;47(4):1274-80 – reference: 15998204 - Behav Neurosci. 2005 Jun;119(3):821-33 – reference: 22820144 - Neurobiol Dis. 2012 Dec;48(3):271-81 – reference: 16269007 - J Neurochem. 2006 Jan;96(1):160-70 – reference: 5276777 - Proc Natl Acad Sci U S A. 1971 Mar;68(3):662-6 – reference: 18573342 - Neurobiol Dis. 2008 Sep;31(3):406-12 – reference: 7842501 - Brain Res Dev Brain Res. 1994 Oct 14;82(1-2):136-42 – reference: 16243425 - Prog Neurobiol. 2005 Sep-Oct;77(1-2):128-38 – reference: 12655058 - Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):4245-50 – reference: 17905480 - Neurobiol Aging. 2009 May;30(5):731-8 – reference: 18215235 - Eur J Neurosci. 2008 Jan;27(2):388-95 – reference: 12373520 - Amino Acids. 2002;23(1-3):65-70 – reference: 14973278 - Development. 2004 Mar;131(5):1145-55 – reference: 1933245 - Brain. 1991 Oct;114 ( Pt 5):2283-301 – reference: 12702666 - Development. 2003 Jun;130(11):2535-42 – reference: 1487080 - Dev Psychobiol. 1992 Dec;25(8):543-55 – reference: 20437561 - Ann Neurol. 2010 May;67(5):639-47 – reference: 22309633 - Eur J Neurol. 2012 Jun;19(6):870-5 – reference: 15950611 - Dev Biol. 2005 Jun 15;282(2):467-79 – reference: 18980217 - Dev Psychobiol. 2009 Jan;51(1):84-94 – reference: 17919745 - Behav Brain Res. 2008 Jan 25;186(2):208-14 – reference: 15301609 - Behav Neurosci. 2004 Aug;118(4):835-44 – reference: 12829322 - Brain Res Mol Brain Res. 2003 Jun 10;114(2):123-31 – reference: 1387836 - Brain Res Dev Brain Res. 1992 Jul 24;68(1):17-22 – reference: 15856447 - Ment Retard Dev Disabil Res Rev. 2005;11(1):4-13 – reference: 22429667 - J Neurol Sci. 2012 Jun 15;317(1-2):80-6 – reference: 8387314 - Behav Neurosci. 1993 Apr;107(2):370-6 |
SSID | ssj0004045 |
Score | 2.114432 |
Snippet | Studies of fetal rodents have provided evidence that early emerging behaviors, such as the suckling response, are dependent on the developing dopaminergic... |
SourceID | pubmed |
SourceType | Index Database |
StartPage | 749 |
SubjectTerms | Analysis of Variance Animals Disease Models, Animal Dopamine Agents - therapeutic use Dose-Response Relationship, Drug Extremities - physiopathology Female Fetal Diseases - drug therapy Fetal Diseases - genetics Homeodomain Proteins - genetics Levodopa - therapeutic use Male Mice Mice, Inbred C57BL Mice, Transgenic Motor Activity - drug effects Mouth - drug effects Pregnancy Substantia Nigra Transcription Factors - genetics |
Title | L-dopa reverses behavioral deficits in the Pitx3 mouse fetus |
URI | https://www.ncbi.nlm.nih.gov/pubmed/25150543 |
Volume | 128 |
hasFullText | |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1NT9wwELWgXLhUlI8WKMgHxAWZZm0n3ki9IARatYA4AOKGYntcrbQkK8gB-PWM7WQTPlq1vURRrESrvLf2zHjeCyE7PDcgeCIZskUyOQBgGpc1lhquHJ4kwvjSwOlZNrqUP67T665_PqhLar1vnt7VlfwPqngNcfUq2X9AdvZQvIDniC8eEWE8_hXGJ8xizuvlJ-BbMfqaewveGqK-b_sYz8f1g9jzeT7sOaibdL_dze3u6_lbziD_OfE2T6GCjstJr_pZVbEqM4pxZFdZvaqqX7aRApmq29QpTSzjTu_Gk0YD0VQcBrLXvQFxlsxFzrwT_4tplA97fOlPiiqakr6ZrKPcX5cQMpUoueyhNr0NsGEAhlFa9HL68-gr4-x2aJ7MYwrhv4nqCzmtZBZD2datVqhv3Y_w7tDNja8yjRBxXCyRj02qQA8i7p_IHJTLZOWgLOrq9pHu0tC8G3ZFlsnibCF7XCHfIy9oywva8YK2vKDjkiJmNPCCBl7QwItVcnl8dHE4Ys1XMliRJrJmxqVKANfOJToRNkvsMFEORKpUJjUoIQqd5CZ1QliupYPcaa1VKgfW8Uw5vkY-lFUJXwjF5xhdOG6KIUgLRZENnDIqy42VwrlinXyOL-RmGq1QbtpXtfHbkU2y2HHoK1lw-N-DLQzkar0dIHkGrD9Igw |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=L-dopa+reverses+behavioral+deficits+in+the+Pitx3+mouse+fetus&rft.jtitle=Behavioral+neuroscience&rft.au=Kleven%2C+Gale+A&rft.au=Booth%2C+Heather+M&rft.au=Voogd%2C+Marco&rft.au=Ronca%2C+April+E&rft.date=2014-12-01&rft.eissn=1939-0084&rft.volume=128&rft.issue=6&rft.spage=749&rft_id=info:doi/10.1037%2Fbne0000016&rft_id=info%3Apmid%2F25150543&rft_id=info%3Apmid%2F25150543&rft.externalDocID=25150543 |